Skip to main content

Kim Kardashian reveals Kate Moss as star of new SKIMS campaign with topless photo: 'She is the fashion icon'

Kim Kardashian reveals Kate Moss as star of new SKIMS campaign with topless photo.

Model Kate Moss appeared as the newest face of Kim Kardashian's shapewear brand SKIMS.

Moss posed topless for the ad campaign, which was released Tuesday.

"I've been a fan of SKIMS since day one," Moss said in a statement, according to People magazine. "What Kim is doing with the brand is so fresh and modern, making underwear women actually want and that fits perfectly."

Kardashian said she was "honored" to feature Moss as the face of the brand.

TEAM USA, KIM KARDASHIAN'S SKIM LINE PARTNER ON OFFICAL LOUNGEWEAR

Kim Kardashian revealed model Kate Moss is the face of her shapewear brand SKIMS for the 2021 summer season. Kardashian and Moss recently spent time together in Rome. 

"I first met Kate in 2014 through [designer] Riccardo Tisci and was instantly struck by her cheeky humor, authentic and classic beauty — we've been friends ever since," Kardashian said in a statement.

KIM KARDASHIAN DIDN'T RETOUCH HER WAIST IN SKIMS AD

"She is THE fashion icon, defining whole generations of culture and style and I am honored to feature her as the new face of SKIMS this Summer!"

Kardashian and Moss were spotted in Rome at the end of June. It's unclear if the trip was connected to Moss' debut as the newest SKIMS ambassador.

SKIMS recently made headlines after Kardashian revealed the brand was outfitting all of the USA female athletes for the Tokyo Olympics with SKIMS undergarments, loungewear and sleepwear. CLICK HERE TO SIGN UP FOR THE ENTERTAINMENT NEWSLETTER

All 626 athletes will receive the full collection. Kardashian released a statement about the news on her Instagram. CLICK HERE TO BUY KIM KARDASHIAN SHAPEWEAR

"Ever since I was 10 years old, I’ve heard every single detail about the Olympics from my stepdad. As I would watch the athletes compete, I would grow to understand the dedication and honor being a part of the Olympics embodied."

Comments

Post a Comment

Popular posts from this blog

Who is the first and only President to instigate a coup?

Dark Brandon Vs Donald Hoover Trump
Post a Comment
Read more

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions. In the wake of contentious legal battles and polarizing decisions, the question arises: Can the "Make America Great Again" (MAGA) movement launch attacks against the Supreme Court over its rulings? As the highest court in the land, the U.S. Supreme Court is often a focal point of scrutiny and criticism from various political factions, but the extent to which these attacks can influence or undermine its authority is a matter of debate and legal interpretation. Historical Context:  Throughout American history, the Supreme Court has faced criticism and resistance from various quarters. From landmark decisions on civil rights and social issues to contentious rulings on political matters, the Court has been no stranger to public backlash. However, the principles of judicial independence and the separation of powers enshrined in the
Post a Comment
Read more

Treatment of erectile dysfunction in adult males aged 22 years and over

  Treatment of erectile dysfunction in adult males aged 22 years and over . U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.0 6 . 0 2 Silver Spring, M D 20993 www.fda.gov June 9, 2023 Re: DEN220078 Trade/Device Name: Eroxon Regulation Number: 21 CFR 876.5021 Regulation Name: Non- medicated top ical formula tion for trea tment of erec tile dysfu nction Regulatory Class: II Product Code: QWW Dated: January 4, 2023 Received: March 28, 2023 Dear Ken James: The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your De Novo request for classification of the Eroxon, an over- the - counter device under 21 CFR Part 801 Subpart C with the following indications for use: Treatment of erectile dysfunction in adult males aged 22 years and over. FDA concludes that this device should be classified into Class II. Th is order, therefor
Post a Comment
Read more